Global Manufacturing Footprint Unither Pharmaceuticals operates eight manufacturing plants across France, the USA, Brazil, and China, demonstrating a strong global presence that can support multinational pharmaceutical companies seeking reliable sterile unit-dose manufacturing capabilities worldwide.

Innovative Technologies With expertise in niche technologies such as Blow Fill & Seal and Liquid Stick-Pack, Unither is well-positioned to serve clients requiring advanced, cost-effective sterile packaging solutions for specialized pharmaceutical products.

Expanding Capacity Recent investments of over 100 million dollars in US facilities highlight Unither’s commitment to increasing production capacity and modernizing operations, offering opportunities for partners looking for scalable manufacturing collaborations.

Strategic Collaborations Partnerships such as the development of combined prophylactic vaccines with biotech firms like ONCOVITA suggest Unither’s openness to joint ventures in innovative health solutions, opening avenues for co-development and licensing deals.

Market Diversification Having products sold in over 100 countries combined with acquisitions like the Novartis site, Unither presents a diverse and expanding customer base, ideal for suppliers of complementary pharmaceutical ingredients, packaging materials, or distribution services.